drugset / Trial / NCT00361309

SU011248 in Advanced Hepatocellular Carcinoma

NCT00361309 ↗

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The main purpose of this study is to begin to collect information and try to learn whether SU011248 works in treating patients with advanced liver cancer. Laboratory studies have shown that SU011248 may block the growth of blood vessels in tumors, which may prevent tumors from growing any further.

Timeline

Start
2006-04
Primary completion
2007-11
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Sunitinib Small molecule 37.5 mg Oral